The Peptide Operator Handbook

What You Get

Six sections. Real operating context.

The Handbook doesn't just describe the rules — it shows you exactly how to apply them to your business, what defensible documentation looks like, and where the actual liability traps are.

The Five Agreement Types — 503A, 503B, API Supply, Telehealth, Approved-Drug — with a decision table
The Red/Yellow/Green Field Guide — 4 illegal behaviors, 5 gray-zone behaviors, and the pure green benchmarks
Chain of Care Framework — how authority, product, and evidence must travel together through the patient care sequence
Six questions to ask before signing any supplier agreement
Five draft agreement templates (503A, 503B, API Supply, Telehealth, Supplier Evaluation Checklist)

"The word 'distribution' appears in almost every bad peptide supply agreement. Here's exactly why — and what correct language actually looks like."

Who it's for

The Handbook is the right starting point if you've asked yourself any of these questions:

"Am I operating legally, or do I think I am?"
"I found a supplier offering 'distribution rights' — is that real?"
"What would an FDA inspector find if they walked in today?"
"I signed some agreements already — should I be worried?"

What's Inside

The Handbook Structure

Section 1 — The Core Problem

Why 'distribution' is the wrong frame for compounded peptide relationships. FDA-approved drug vs. compounded peptide.

Section 2 — The Five Legitimate Agreement Types

503A, 503B, API Supply, Telehealth, Approved-Drug. Which paper fits which operating relationship — decision table.

Section 3 — The Chain of Care Framework

How authority, product, and evidence must travel together. Patient evaluation → prescription → compounding → dispensing → follow-up.

Section 4 — Supplier Agreement Evaluation

Six questions to ask before signing anything. Red/Yellow/Green Field Guide. The real-world green-yellow pathway.

Section 5 — If You Already Signed the Wrong Paper

Gathering the paper trail. Legal review checklist. Pausing vs. continuing while under review.

Section 6 — The Business Case for Getting This Right

What a 503B warning letter or FDA consent decree actually costs vs. building it right the first time.

Get the Handbook + Everything Else

The Handbook is included in the All-Access Membership — along with the Course, Monthly Compliance Digest, and everything we publish.

$57/mo

Monthly · 2 devices

$575/yr

Annual · 5 devices

Start All-Access →

Cancel anytime. Secure checkout via Stripe.

AEG Peptide & Wellness Compliance is an operational compliance resource, not a law firm. Content is educational and informational — it does not constitute legal advice. Consult a licensed attorney for advice specific to your business situation.